• OUR DATA
  • BUY REPORTS & LISTS
  • OUR BLOG
 

Download a FREE copy of B2B Selling for Dummies Now!



JOHNSON & JOHNSON Revenue and Financial Data

It's difficult to get well without Johnson & Johnson (J&J). The diversified health care giant operates in three segments through more than 270 operating companies located in some 60 countries. Its Medical Devices and Diagnostics division offers surgical equipment, monitoring devices, orthopedic products, and contact lenses, among other things. J&J's Pharmaceuticals division makes drugs for an array of ailments, such as neurological conditions, blood disorders, autoimmune diseases, and pain. Top sellers are psoriasis drug Remicade and cancer medication Velcade. Its Consumer business makes over-the-counter drugs and products for baby, skin, and oral care, as well as first aid and nutritional uses.

Financials Information for JOHNSON & JOHNSON

Track this company’s financial condition.
View Company Report
Request Your Free Trial

  • Income Statement
  • Cash Flow
  • Balance Sheet
  • Credit Rating
Income Statement 2013 2012 2011 2010 2009
Revenue $71,312 $67,224 $65,030 $61,587 $61,897
Gross Profit $48,970 $45,566 $44,670 $42,795 $43,450
Operating Income $18,377 $15,869 $16,153 $16,527 $15,590
Net Income $13,831 $10,853 $9,672 $13,334 $12,266
Diluted EPS $4.81 $3.86 $3.49 $4.78 $4.4
Cash Flow (mil) 2013 2012 2011
Cash at the beginning of the year $ $ $
Net Operating Cash $17,414 $15,396 $14,298
Net Investing Cash $(5,103) $(4,510) $(4,612)
Net Financing Cash $(6,091) $(20,562) $(4,452)
Net Change in Cash $6,016 $(9,631) $5,187
Cash at end of the year $20,927 $14,911 $24,542
Capital Expenditure $(3,595) $(2,934) $(2,893)
Assets (mil) 2013 2012 2011
Current Assets
Cash $20,927 $14,911 $24,542
Net Receivables $11,713 $11,309 $10,581
Inventories $7,878 $7,495 $6,285
Other Income Assets $15,889 $12,401 $12,908
Asset Summary
Total Current Assets $56,407 $46,116 $54,316
Net Fixed Assets $16,710 $16,097 $14,739
Other Noncurrent Assets $59,566 $59,134 $44,589
Total Assets $132,683 $121,347 $113,644
Liabilities (mil) 2013 2012 2011
Current Liabilities
Accounts Payable $6,266 $5,831 $5,725
Short Term Debt $4,852 $4,676 $6,658
Other Current Liabilities $14,557 $13,755 $10,428
Liability Summary
Total Current Liabilities $25,675 $24,262 $22,811
Long Term Debt $13,328 $11,489 $12,969
Other Noncurrent Liabilities $19,627 $20,770 $20,784
Total Liabilities $58,630 $56,521 $56,564
Stakeholder's Equity (mil) 2013 2012 2011
Equity
Preferred Stock Equity $0 $0 $0
Common Stock Equity $74,053 $64,826 $57,080
Equity Summary
Total Equity $74,053 $64,826 $57,080
Shares Outstanding 2,820.6299 2,778.49 2,730.8501

Credit Rating

Low
These businesses have a low projected risk of delinquency and a moderate to low risk of failure.

Need to go deeper? No problem.

  • Save time with complex financial data at your fingertips
  • Access financial statements, SEC filings, earnings estimates, and more
  • Call (866) 473-3932 to talk to a Business Information Consultant